{"Exaggerate": "The claim may be exaggerating the idea that Daraprim is underpriced relative to its peers.", "Lack enough support": "The claim does not provide enough evidence or support to justify the assertion that Daraprim is underpriced.", "Problematic assumption": "The claim assumes that the price of Daraprim should be compared to other drugs in the market, which may not be a fair or accurate comparison.", "Exist alternative explanation": "There may be alternative explanations for the high price of Daraprim, such as the company's desire for profit rather than altruism."}